Here, we showed that DAHP treatment with the consequent reduction of NO and increase of the ROS levels was able to inhibit AKT and ERK phosphorylation in WM983B metastatic melanoma cells (Figure 9B). The gene discussed is AKT1; the disease is metastatic melanoma.